7,11,14-Eicosatrienoic acid

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 7,11,14-Eicosatrienoic acid
• 英文别名: (7E,11E,14E)-icosa-7,11,14-trienoic acid
• 化学式: C₂₀H₃₄O₂
• 分子量: 306.5
• InChiKey: PTZVBFWVXXLKST-JRVLCRGASA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.7
• 重原子数：
  22
• 可旋转键数：
  15
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.65
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• Lipid formulations containing bioactive fatty acids
  申请人：SCIADONICS, INC.

  公开号：US11058656B2

  公开（公告）日：2021-07-13

  Provided herein is technology relating to lipid compositions containing bioactive fatty acids and particularly, but not exclusively, to compositions containing defined ratios of 5,11,14-eicosatrienoic acid to one or more of: 5,9,12-octadecatrienoic acid; 7,11,14-eicosatrienoic acid; 5,8,11,14-eicosatetraenoic acid; 9,12-octadecadienoic acid; 9-octadecenoic acid; 14-methyl hexadecanoic acid; 11,14 eicosadienoic acid, 5,9-octadecadienoic acid; 5,11-octadecadienoic acid; 9,12,15-octadecatrienoic acid; 5,8,11,14,17-eicosapentaenoic acid; 7,10,13,16,19-docosapentaenoic acid; and 4,7,10,13,16,19-docosahexaenoic acid.

  本文提供的技术涉及含有生物活性脂肪酸的脂质组合物，特别是（但不限于）含有确定比例的 5,11,14-二十碳三烯酸与下列一种或多种物质的组合物：5,9,12-octadecatrienoic acid; 7,11,14-eicosatrienoic acid; 5,8,11,14-eicosatetraenoic acid; 9,12-octadecadienoic acid; 9-octadecenoic acid; 14-methyl hexadecanoic acid; 11,14-eicosadienoic acid, 5,9-octadecadienoic acid；5,11-十八碳二烯酸；9,12,15-十八碳三烯酸；5,8,11,14,17-二十碳五烯酸；7,10,13,16,19-二十碳五烯酸；以及 4,7,10,13,16,19-二十二碳六烯酸。
• PET FOOD COMPOSITIONS, METHOD OF TREATING AN INFLAMMATORY CONDITION AND METHOD OF REDUCING CICULATPRO-INFLAMMATORY CYTOKINES
  申请人：Hill's Pet Nutrition, Inc.

  公开号：EP3855932A1

  公开（公告）日：2021-08-04
• LIPID FORMULATIONS CONTAINING BIOACTIVE FATTY ACIDS
  申请人：SCIADONICS, INC.

  公开号：US20180353453A1

  公开（公告）日：2018-12-13

  Provided herein is technology relating to lipid compositions containing bioactive fatty acids and particularly, but not exclusively, to compositions containing defined ratios of 5,11,14-eicosatrienoic acid to one or more of: 5,9,12-octadecatrienoic acid; 7,11,14-eicosatrienoic acid; 5,8,11,14-eicosatetraenoic acid; 9,12-octadecadienoic acid; 9-octadecenoic acid; 14-methyl hexadecanoic acid; 11,14 eicosadienoic acid, 5,9-octadecadienoic acid; 5,11-octadecadienoic acid; 9,12,15-octadecatrienoic acid; 5,8,11,14,17-eicosapentaenoic acid; 7,10,13,16,19-docosapentaenoic acid; and 4,7,10,13,16,19-docosahexaenoic acid.
• Pet Food Compositions, Method of Treating an Inflammatory Condition and Method of Reducing Ciculatpro-Inflammatory Cytokines
  申请人：Hill's Pet Nutrition, Inc.

  公开号：US20220000826A1

  公开（公告）日：2022-01-06

  Described herein are pet food compositions for reducing circulating pro-inflammatory cytokines in companion animals Methods of treatment and reduction of reducing circulating pro-inflammatory cytokines are also described. The pet food compositions may comprise more than 0.1 w % of polyunsaturated fatty acids having 20 or more carbons and a botanical as well as a nutritionally complete carrier. A dietary composition comprising epigallocatechin-3-gallate and more than 0.10 w % of arachidonic acid is also claimed.
• [EN] LIPID FORMULATIONS CONTAINING BIOACTIVE FATTY ACIDS<br/>[FR] FORMULATIONS LIPIDIQUES CONTENANT DES ACIDES GRAS BIOACTIFS
  申请人：SCIADONICS INC

  公开号：WO2017091647A1

  公开（公告）日：2017-06-01

  Provided herein is technology relating to lipid compositions containing bioactive fatty acids and particularly, but not exclusively, to compositions containing defined ratios of 5,11,14-eicosatrienoic acid to one or more of: 5, 9, 12-octadecatrienoic acid; 7, 11, 14-eicosatrienoic acid; 5, 8, 11, 14-eicosatetraenoic acid; 9, 12-octadecadienoic acid; 9-octadecenoic acid; 14-methylhexadecanoic acid; 11, 14 eicosadienoic acid, 5, 9-octadecadienoic acid; 5, 11-octadecadienoic acid; 9, 12, 15-octadecatrienoic acid; 5,8,11,14,17-eicosapentaenoic acid; 7,10,13,16,19-docosapentaenoic acid; and 4,7,10,13,16,19-docosahexaenoic acid.